SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: paul goldstein who wrote (3607)5/9/1998 2:26:00 PM
From: John H. Farro  Read Replies (2) of 4342
 
Paul, I know that the company got good preliminary data from AndroCar's compassionate use trial, but this was based on a very small sample size. I think there were only 7 or 9 people involved. I also know that the company announced that they were expanding the program and that they had expected results by the end of June. I am assuming they never completed the expanded trial because they never issued a press release announcing the results. I just wonder if they got any useful data out of the trial before it was cancelled. Could they say for example:

"We wanted to enroll 30 more people for 6 months but we only got to enroll 10 people for 2 months. We didn't get as much data as we had hoped for, but we saw significant tumor shrinkage in 7 of those 10 people?"

If they got some indication of how the results would have turned out then this may help them in persuading a large pharmaceutical company to assist them in conducting the tests necessary before releasing AndroCar as a cancer drug.

Paul, you said:

i am still convinced it could be a winner..but, reality sets in and we must wait for firm results or news that justifies being bullish.

I couldn't agree with you more about the necessity of awaiting firm news before becoming excessively bullish.

Robin
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext